Literature DB >> 30925072

Strength-duration relationship as a tool to prioritize cardiac tissue properties that govern electrical excitability.

Michael N Sayegh1,2, Natasha Fernandez1, Hee Cheol Cho1,2.   

Abstract

Engineered cardiac tissue and cardiomyocyte cell cultures offer wide opportunities for improved therapeutic intervention and laboratory heart models. Electrical field excitation is a common intervention in the production of engineered tissue and the investigation of the electrical properties of in vitro cell cultures. In this work, we use strength-duration relationships to investigate systematically factors influencing electrical excitability of two- (2D) and three-dimensional (3D) neonatal rat ventricular myocyte cultures. We find that the strength of the voltage pulse is negatively correlated with the threshold duration, as predicted by the Lapicque-Hill equation, and show that higher pacing frequencies require higher thresholds to capture paced cultures. We also study the impact of properties intrinsic to the 2D and 3D cultures on strength-duration relationships. We show that a smaller culture dimension, perpendicular anisotropic culture orientation with respect to electrical field, higher proportion of added fibroblasts, and TBX18-induced pacemaker reprogramming independently result in higher stimulation thresholds. These properties reflect the characteristics of the well-insulated endogenous pacemaking tissue in the heart (sinoatrial node) and should guide the engineering of biological pacemakers for improved outcomes. NEW & NOTEWORTHY Gaps exist in the availability of in vitro functional assessment tools that can emulate the integration of regenerative cells and tissues to the host myocardium. We use strength-duration relationships of electrically stimulated two- and three-dimensional myocardial constructs to study the effects of pacing frequency, culture dimensions, anisotropic cell alignment, fibroblast content, and pacemaker phenotype on electrical excitability. Our study delivers electrical strength-duration as a quantifiable parameter to evaluate design parameters of engineered cardiac tissue constructs.

Entities:  

Mesh:

Year:  2019        PMID: 30925072      PMCID: PMC7199233          DOI: 10.1152/ajpheart.00161.2019

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  43 in total

1.  Development of a drug screening platform based on engineered heart tissue.

Authors:  Arne Hansen; Alexandra Eder; Marlene Bönstrup; Marianne Flato; Marco Mewe; Sebastian Schaaf; Bülent Aksehirlioglu; Alexander P Schwoerer; Alexander Schwörer; June Uebeler; Thomas Eschenhagen
Journal:  Circ Res       Date:  2010-05-06       Impact factor: 17.367

2.  Real-time measurement of the contractile forces of self-organized cardiomyocytes on hybrid biopolymer microcantilevers.

Authors:  Jungyul Park; Jaewook Ryu; Seung Kyu Choi; Eunseok Seo; Jae Min Cha; Seokchang Ryu; Jinseok Kim; Byungkyu Kim; Sang Ho Lee
Journal:  Anal Chem       Date:  2005-10-15       Impact factor: 6.986

3.  Microfabricated perfusable cardiac biowire: a platform that mimics native cardiac bundle.

Authors:  Yun Xiao; Boyang Zhang; Haijiao Liu; Jason W Miklas; Mark Gagliardi; Aric Pahnke; Nimalan Thavandiran; Yu Sun; Craig Simmons; Gordon Keller; Milica Radisic
Journal:  Lab Chip       Date:  2014-03-07       Impact factor: 6.799

4.  Microfabricated tissue gauges to measure and manipulate forces from 3D microtissues.

Authors:  Wesley R Legant; Amit Pathak; Michael T Yang; Vikram S Deshpande; Robert M McMeeking; Christopher S Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2009-06-16       Impact factor: 11.205

5.  Transcriptional suppression of connexin43 by TBX18 undermines cell-cell electrical coupling in postnatal cardiomyocytes.

Authors:  Nidhi Kapoor; Giselle Galang; Eduardo Marbán; Hee Cheol Cho
Journal:  J Biol Chem       Date:  2011-01-04       Impact factor: 5.157

6.  On establishing primary cultures of neonatal rat ventricular myocytes for analysis over long periods.

Authors:  A Lokuta; M S Kirby; S T Gaa; W J Lederer; T B Rogers
Journal:  J Cardiovasc Electrophysiol       Date:  1994-01

7.  Biomimetic platforms for human stem cell research.

Authors:  Gordana Vunjak-Novakovic; David T Scadden
Journal:  Cell Stem Cell       Date:  2011-03-04       Impact factor: 24.633

8.  Biological pacemaker created by minimally invasive somatic reprogramming in pigs with complete heart block.

Authors:  Yu-Feng Hu; James Frederick Dawkins; Hee Cheol Cho; Eduardo Marbán; Eugenio Cingolani
Journal:  Sci Transl Med       Date:  2014-07-16       Impact factor: 17.956

9.  [Age-related structural changes in the stimuli-conducting system of the human heart].

Authors:  I Buruljanowa; G Wassilew; S Radanov
Journal:  Zentralbl Allg Pathol       Date:  1987

10.  Structural and functional evidence for discrete exit pathways that connect the canine sinoatrial node and atria.

Authors:  Vadim V Fedorov; Richard B Schuessler; Matthew Hemphill; Christina M Ambrosi; Roger Chang; Alexandra S Voloshina; Kathy Brown; William J Hucker; Igor R Efimov
Journal:  Circ Res       Date:  2009-02-26       Impact factor: 17.367

View more
  3 in total

Review 1.  Implementing Biological Pacemakers: Design Criteria for Successful.

Authors:  Elizabeth R Komosa; David W Wolfson; Michael Bressan; Hee Cheol Cho; Brenda M Ogle
Journal:  Circ Arrhythm Electrophysiol       Date:  2021-10-01

2.  Induced cardiac pacemaker cells survive metabolic stress owing to their low metabolic demand.

Authors:  Jin-Mo Gu; Sandra I Grijalva; Natasha Fernandez; Elizabeth Kim; D Brian Foster; Hee Cheol Cho
Journal:  Exp Mol Med       Date:  2019-09-13       Impact factor: 8.718

3.  Engineered Cardiac Pacemaker Nodes Created by TBX18 Gene Transfer Overcome Source-Sink Mismatch.

Authors:  Sandra I Grijalva; Jin-Mo Gu; Jun Li; Natasha Fernandez; Jinqi Fan; Jung Hoon Sung; Seung Yup Lee; Conner Herndon; Erin M Buckley; Sung-Jin Park; Flavio H Fenton; Hee Cheol Cho
Journal:  Adv Sci (Weinh)       Date:  2019-09-30       Impact factor: 16.806

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.